SPOTLIGHT -
Poll
Author(s):
What percentage of depressed patients are resistant to treatment with conventional antidepressant medication?
April in Review: Updates on the Psychiatric Treatment Pipeline
Here's to a Psychedelic Revolution
Preliminary Results from RESTORE-LIFE Shows Promise for VNS in Difficult to Treat Depression
Blue Light Blockers: A Behavior Therapy for Mania
Cybin Announces Partnership With Osmind to Advance Clinical-Stage Psychiatry Programs
MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder